We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Former GSK and Pfizer joint venture shines
US drugmaker adjusts strategy of pursuing deals to replenish drug pipeline
Demand for over-the-counter remedies rises as rebound in seasonal illnesses combines with Covid-19
Newly listed consumer health group refuses indemnification requests related to heartburn drug
Investors should be wary of the damages a long, drawn out legal battle can inflict
Colds and flu are back, and so is demand for remedies
Investors cool on biggest London listing since Glencore in 2011 on worries about inflation and consumer confidence
Vote to separate consumer healthcare paves way for London’s largest stock market listing in a decade
US pharma group to sell down stake in Haleon business after July IPO
Spinning off the business will make more bolt-on deals possible
As split nears completion, investors turn attention to what comes next
UK drugmaker ‘extremely confident’ despite market uncertainty over Ukraine
UK Edition
